Banzai International (BNZI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Achieved full year 2025 revenue of $12.2 million, up 169% year-over-year, and Q4 2025 revenue of $2.8 million, up 116% from Q4 2024, driven by acquisitions and strong product performance.
Gross margin expanded to 82% for FY2025, up from 68.6% in FY2024, with Q4 gross margin at 81.9%.
Net loss improved to $(22.5) million for FY2025, a 29% improvement from FY2024, with Q4 net loss improving by 36%.
Customer base surpassed 150,000, including blue-chip clients across healthcare, technology, and financial services in over 90 countries.
Strategic acquisitions, including Superblocks and the proposed ConnectAndSell deal, are expected to more than double annualized revenue and enhance platform capabilities.
Financial highlights
Q4 2025 revenue: $2.8 million, up 116% year-over-year; full year 2025 revenue: $12.2 million, up 169%.
Q4 gross profit: $2.3 million, up 148% year-over-year; full year gross profit: $10 million, up 221%.
Gross margin for 2025: 82%, up from 68.6% in 2024.
Q4 net loss: $5 million, improved from $7.9 million year-over-year; full year net loss: $22.5 million, improved from $31.5 million.
Adjusted EBITDA loss for 2025: $7.3 million, slightly higher than $6.5 million in 2024.
Cash at year-end: $0.3 million, with $1.3 million raised post-year-end via ATM agreement.
Stockholders' equity increased by $10.8 million to $8.1 million as of December 31, 2025.
Outlook and guidance
Expectation to more than double annualized revenue to over $27 million upon closing the ConnectAndSell acquisition.
Anticipate ConnectAndSell to be EBITDA accretive in its first full year, with potential for $2–4 million in EBITDA contribution.
Strategic priorities include strengthening the balance sheet, accelerating organic growth, investing in AI innovation, and expanding in BFSI and healthcare verticals.
Continued focus on transitioning CreateStudio to a SaaS model and maintaining an active pipeline of acquisition opportunities.
Latest events from Banzai International
- Registering resale of 702,042 shares amid debt restructuring and ongoing capital needs.BNZI
Registration Filing3 Feb 2026 - Q3 2024 delivered record ARR growth, improved profitability, and major balance sheet restructuring.BNZI
Q3 202414 Jan 2026 - Proxy corrections clarify Marcum as auditor and explain audit date changes after a stock split.BNZI
Proxy Filing9 Jan 2026 - Shelf registration allows up to $30M in offerings as the company pursues SaaS growth amid Nasdaq risks.BNZI
Registration Filing16 Dec 2025 - Registering 1.5M+ shares for resale amid ongoing losses, acquisitions, and Nasdaq compliance risks.BNZI
Registration Filing16 Dec 2025 - Registering 9M shares for resale after $11M note; faces losses, dilution, and Nasdaq risk.BNZI
Registration Filing16 Dec 2025 - Registering up to $30M in securities amid ongoing losses and Nasdaq compliance risks.BNZI
Registration Filing16 Dec 2025 - Registering 9M shares for resale amid losses, dilution risk, and concentrated insider control.BNZI
Registration Filing16 Dec 2025 - Registering 1.5M shares for resale amid losses, dilution risk, and Nasdaq compliance challenges.BNZI
Registration Filing16 Dec 2025